2024 annual financial data
Cocrystal Pharma 2024 Operating margin
Cocrystal Pharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -17,878,000 USD and net income was -17,504,000 USD.
Operating cash flow was -16,485,000 USD.
Get free Cocrystal Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,878,000 USD
- Net income
- -17,504,000 USD
- Operating cash flow
- -16,485,000 USD